Abbott Rapid Dx International Limited Related News
The albumin-to-creatinine ratio: shining a light on early kidney disease
Abbott outlines how albumin-to-creatinine ratio measurement can be leveraged to address the increasing global burden of kidney disease.
Albumin-to-creatinine ratio (ACR) is known to be...
Fighting forward: how to keep antibiotics working with CRP point-of-care testing
Abbott explores how antibiotic use can be reduced in primary care settings and reviews the role of CRP point-of-care testing, its use in different...
How point-of-care testing is optimising cardiovascular and diabetes care
Abbott reflects on the anticipated uptake in rapid, point-of-care technology in cardiovascular and diabetes primary care and proposes steps to smooth the transformation from...
Advances in point-of-care testing and the importance of connectivity
Felicia Longobardi of Abbott outlines key advances in point-of-care testing and how digital connectivity can be used to improve outcomes within healthcare.
In recent years,...
CRP rapid testing for suspected COVID-19 could slow the spread of antimicrobial resistance
Dr Carl Llor reviews recent evidence that C-reactive protein (CRP) rapid testing can be used as a prognostic marker in COVID-19 and contribute to...
Point-of-care medicine: the future of rapid diagnostics in healthcare
Abbott explores how point-of-care diagnostics will evolve in the wake of COVID-19, and showcases a new learning platform that aims to transform knowledge on rapid testing in primary care.
The role of point-of-care testing in the time of COVID-19
Exploring the value of point-of-care C-reactive protein testing in the time of COVID-19 in patient risk assessment and monitoring.
As the healthcare industry’s understanding of...
